Hypercalcemia Treatment Market, by Drug Type (Bisphosphonates (Clodronate, Etidronate, Ibandronate, Pamidronate, and Zoledronic Acid), Calcitonin, Glucocorticoids, Denosumab, Calcimimetics, and Others), by Indication (Primary Hyperthyroidism, Hypercalcemia of Malignancy, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028